Results 111 to 120 of about 38,655 (210)
Bullous pemphigoid is a devastating autoimmune blistering disease with need for improved therapeutics. Limited data are available on the overall burden of pruritus and alterations over time; however, treatment of itch-specific pathways may provide novel ...
Olive C. Osuoji +14 more
doaj +1 more source
Clinicoepidemiological Features of 82 Cases of Bullous Pemphigoid in Tehran, Iran
Bullous Pemphigoid is a chronic immunobullous disease, characterized by subepidermal bulla on the skin and mucosa. The purpose of the present study was to investigate the clinicoepidemiological features of bullous pemphigoid in Iranian patients.
Kamran Balighi +5 more
doaj
Two pemphigoid cases with mucous membrane involvement successfully treated with baricitinib
Both bullous pemphigoid and mucous membrane pemphigoid are autoimmune bullous diseases that can be challenging to treat in individual cases. Janus kinase inhibitors have shown efficacy in several autoimmune and inflammatory diseases, although these drugs
Tamás Malkovics +2 more
doaj +1 more source
International Journal of Dermatology, Volume 65, Issue 2, Page 356-358, February 2026.
Noor Mruwat +3 more
wiley +1 more source
Jo-David Fine, Jo-David Fine
semanticscholar +1 more source
Childhood bullous pemphigoid [PDF]
Dipti, Das +2 more
openaire +2 more sources
Depression and Anxiety in Patients with Bullous Pemphigoid: Impact and Management Challenges
Nicolas Kluger, Anna Pankakoski, Jaana Panelius Department of Dermatology, Allergology and Venereology, Helsinki University Hospital, Helsinki, FinlandCorrespondence: Nicolas KlugerDepartment of Dermatology, Skin and Allergies Hospital, Meilahdentie 2 ...
Kluger N, Pankakoski A, Panelius J
doaj
Refractory ocular mucous membrane pemphigoid treated successfully with upadacitinib
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 1, Page 76-78, January 2026.
Vincenzo Maione +6 more
wiley +1 more source
Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination
M. Tomayko +9 more
semanticscholar +1 more source

